Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Effective and safe – Evaluation of the first ten years of colonoscopy in cancer screening

No. 55 | 04/11/2014 | by Koh

Scientists at the German Cancer Research Center (DKFZ) have evaluated data from the first ten years of endoscopic gastrointestinal cancer screening (colonoscopy). The study concludes that the approximately 4.4 million screening examinations conducted during this period have prevented about 180,000 cases of colorectal cancer. By comparison, there were only 4,500 cases of over-diagnosis.


In 2002, Germany was one of the first countries worldwide to introduce colonoscopy as part of its national statutory cancer screening program. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now looked back on the first ten years of this program to evaluate its effectiveness: how many cases of cancer did it prevent? How many tumors were detected early in the course of the disease? And what about cases of over-diagnosis, where the method indicated a malignancy that would not have become clinically significant during a person’s lifetime?

In the current study, the researchers evaluated the medical reports of 4.4 million screening colonoscopies conducted between 2003 and 2012. “This is the most comprehensive evaluation of a[s1]  national screening colonoscopy program to date,” says study head Prof. Hermann Brenner of the DKFZ, who was in charge of the study.

The calculations are based on a mathematical model that takes into account not only medical reports and mortality rates, but also other factors such as the incidence of different types of precancerous lesions and the course of time over which they turn into colorectal cancer.

During these first ten years of endoscopic gastrointestinal screening, a total of 180,000 precancerous lesions were discovered and immediately removed during the examination. Additionally, physicians found over 40,000 cases of early-stage colorectal cancer, a phase in which the disease is still curable in most cases. In contrast, there were only about 4,500 cases of over-diagnosis.

“In about one out of 28 colonoscopy examinations, a physician finds a precancerous lesion and thus prevents a cancer case,” says Dr. Michael Hoffmeister, one of the authors of the publication. “In one out of 121 examinations, doctors detect a malignant tumor early on. But only one out of 1,089 examinations leads to an over-diagnosis.” He adds: “In participants under 75 years of age, only 0.4 percent of gastrointestinal endoscopic exams result in an over-diagnosis. This means that colonoscopy screening produces significantly better results than other cancer screening programs. Mammography, for example, has a much higher over-diagnosis rate.”

Endoscopic examinations have the highest chance of preventing a case of cancer if conducted at around the age of 60 years. Increasing age of the subjects is accompanied by a rise in the rate of over-diagnosis.

Brenner’s conclusion is crystal clear: “In the long term, colonoscopy will lower colorectal cancer mortality. Moreover, endoscopic screening is a real means of prevention. As opposed to other screening programs, it will also significantly lower the incidence of new cancer cases.”

Hermann Brenner, Lutz Altenhofen, Christian Stock, Michael Hoffmeister: Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany. Clinical Gastroenterology and Hepatology 2014, DOI: 10.1016/j.cgh.2014.08.036

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS